Objective To improve the techniques for minimal residual disease (MRD) detection in acute lymphoblastic leukemia (ALL).
目的探索提高急性淋巴细胞白血病(all)微量残留病(MRD)检测技术。
Objective to investigate the significance of serial monitoring of minimal residual disease (MRD) in patients with acute lymphoblastic leukemia (ALL).
目的探讨急性淋巴细胞白血病(all)微量残留病(MRD)检测的临床意义。
Conclusion Monitoring of the WT1 gene by Nest RTPCR would be a surely marker for the detection of minimal residual disease (MRD) in acute leukemia.
结论用Nest、RT - PCR测定WT 1基因的表达可作为检测白血病微小残留病(MRD)的一项指标。
应用推荐